Eagle Meds Services
Yeztugo (LENACAPAVIR SODIUM)
Available to sourceHuman Prescription DrugOncology & Specialty

Yeztugo (LENACAPAVIR SODIUM)

300 mg/1 · Film-Coated Tablet
By Gilead Sciences, Inc.
NDC
61958-3401
Route
Oral
Therapeutic class
Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Capsid Inhibitors [MoA], Human Immunodeficiency Virus 1 Capsid Inhibitor , P-Glycoprotein Inhibitors [MoA]
Marketing category
NDA

Package sizes

  • 4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-3401-1)NDC 61958-3401-1Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
Yeztugo (LENACAPAVIR SODIUM)
NDC 61958-3401